Liberty Health Sciences Inc. (CNSX:LHS) entered into a binding term sheet to acquire 242 Cannabis, LLC on January 4, 2018. Under the terms of consideration, Liberty Health will issue 18.82 million units with each unit being comprised of one common share and one-half common share purchase warrant, with each whole warrant exercisable at CAD 2.07 for a period of three years from the closing date. Liberty Health Sciences Inc. (CNSX:LHS) entered into a definitive agreement to acquire 242 Cannabis, LLC on January 31, 2018. The transaction is subject to customary conditions, standard due diligence including title, environmental assessments and surveys as well as the satisfaction of conditions precedent in accordance with the purchase and sale contract. The transaction is expected to close on or prior to February 9, 2018. Curtis Cusinato, Daniel Howard and J.B Elliott of Stikeman Elliott LLP acted as legal advisers to Liberty Health Sciences Inc.